| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/27/2008 | CN101129355A Lovastatin sustained-release tablets and method of producing the same |
| 02/27/2008 | CN101129353A Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket |
| 02/27/2008 | CN101129352A Use of oral conjugation linolic acid calcium for skin beauty treatment |
| 02/27/2008 | CN101129351A Iron supplement composition, its preparing method and application of the same |
| 02/27/2008 | CN101129347A Florfenicol oil emulsion injection and method for formulating the same |
| 02/27/2008 | CN101129346A Ambroxol hydrochloride oral cavity disintegrating tablet and method of producing the same |
| 02/27/2008 | CN101129345A Vitamin K1 injection and method of producing the same |
| 02/27/2008 | CN101129342A Method of producing hepatic targeting drug microcapsule |
| 02/27/2008 | CN101129341A Intra-oral disintegration compositions and process for producing same |
| 02/27/2008 | CN101129340A Method of producing nano magnetic polylactic acid composite particle for photodynamic medicament carrier |
| 02/27/2008 | CN101129339A Method of producing nano magnetic chitosan composite particle for photodynamic medicament carrier |
| 02/27/2008 | CN101129338A Minuteness anti-cancer medicine paclitaxel of novel technique supercritical fluid |
| 02/27/2008 | CN101129337A Method of producing water-solubility hypocrellin titanium dioxide nano granule |
| 02/27/2008 | CN101129336A Method of preparing lipid nano granule |
| 02/27/2008 | CN101129335A Use of nano structured lipid carrier drug feeding system |
| 02/27/2008 | CN101129334A Origanum oil emulsion and technique of preparing the same |
| 02/27/2008 | CN101129333A Method of preparing nano slow release agent for simplifying animal FSH superovulation |
| 02/27/2008 | CN101129332A Malotilate dry emulsion and method of preparing the same |
| 02/27/2008 | CN101129331A Method of preparing transparent water dispersion type lycopene concentrated liquor |
| 02/27/2008 | CN101129330A Method of preparing maduramicin ammonium microemulsion |
| 02/27/2008 | CN101129329A Injection containing huperzine for sulci venosi and method of preparing the same |
| 02/27/2008 | CN101129328A Compound aminophenazone barbital Injection and method of producing the same |
| 02/27/2008 | CN101129327A Micro-projection array having a beneficial agent containing coating |
| 02/27/2008 | CN101129326A Method of preparing smectite suspension agent |
| 02/27/2008 | CN101129314A Health care feet soaking powder and feet soaking patch |
| 02/27/2008 | CN101129225A Multifunctional plaster for navel |
| 02/27/2008 | CN100371340C Production of Rhizoma Picrorhizae glucoside II monomer and its drug form for treating hepatitis B |
| 02/27/2008 | CN100371020C In situ quick preparation method of injectable supermolecular structure water gel and its uses |
| 02/27/2008 | CN100371019C Uro-genital condition treatment system |
| 02/27/2008 | CN100371015C Anti-virus Chinese herbal medicine product |
| 02/27/2008 | CN100371010C Medicinal composite for treating depression, and its preparation method |
| 02/27/2008 | CN100371009C Chinese-medicinal capsules for treating constipation |
| 02/27/2008 | CN100371007C Compound hypoglycemic Chinese medicine and its preparing method and use |
| 02/27/2008 | CN100371002C Chinese medicinal preparation for treating heart cerebrovascular disease and making method thereof |
| 02/27/2008 | CN100371001C Usage of rhubarb root and its extractions in the process for preparing postprandial blood sugar decreasing medicine |
| 02/27/2008 | CN100370998C Chinese medicinal preparation for treating sore, and wound and turn and scald |
| 02/27/2008 | CN100370996C Soft capsule of forest frogoil, royal jelly and seed kernel oil of pinus pumila reg, and its preparing process |
| 02/27/2008 | CN100370995C Sodium triphosphate transfusion and its preparation technique |
| 02/27/2008 | CN100370994C Ointment with clindamycin and metronidazole and method for preparing the same |
| 02/27/2008 | CN100370992C Doxycycline hydrochloride freeze-dried power preparation for injection, and process for preparing same |
| 02/27/2008 | CN100370990C Controlled release galantamine composition |
| 02/27/2008 | CN100370985C Externally applied sprayer formulation for sweat control and deodorization |
| 02/27/2008 | CN100370984C Telmisartan dispersible tablet and its preparation method |
| 02/27/2008 | CN100370982C Anemonin gel |
| 02/27/2008 | CN100370979C Preparation process of glucose eye lotion |
| 02/27/2008 | CN100370978C Composition for treating hemorrhoids |
| 02/27/2008 | CN100370977C Slow release tablet of containing active ingredient of ambroxol hydrochloride |
| 02/27/2008 | CN100370974C Bufonin preparation for cancer treating |
| 02/27/2008 | CN100370973C Traditional Chinese medicinal preparation for treating obstruction of qi in the chest |
| 02/27/2008 | CN100370972C Heart boosting pulse restoring tablet and its preparation method |
| 02/27/2008 | CN100370971C Phacolysin eye medicinal formulation |
| 02/27/2008 | CN100370970C Compound red-rooted salvia preparation, and its preparing method |
| 02/27/2008 | CN100370969C Chinese materia medica preparation for treating dysmenorrhea of women and its preparing method |
| 02/27/2008 | CN100370968C Quercetin long-acting liposome powder for injection and its preparing method |
| 02/27/2008 | CN100370967C Implantable gel compositions and preparing method of thereof |
| 02/26/2008 | US7337011 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 02/26/2008 | US7335766 dissolving an acid-soluble chitosan in organic acid; spraying the chitosan solution on salt particles to bind the chitosan to the salt particles; and drying the chitosan-bound salt particles |
| 02/26/2008 | US7335682 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | US7335639 IGF-1 composition and its use |
| 02/26/2008 | US7335613 Persistent, durable, broad spectrum antimicrobial activity; for diapers, feminine hygiene products, laundry aids, wound care products, carpets etc |
| 02/26/2008 | US7335509 Drug/lipid/polycation complexes; gene therapy |
| 02/26/2008 | US7335401 Producing protein-coated polystyrene particles; comprising combining suspension of uncoated microparticles with bioaffinity binding pair, incubate, allow adsorption and recover coated particle |
| 02/26/2008 | US7335389 Beverages containing plant sterols |
| 02/26/2008 | US7335380 Tablet, without excessive stickiness or tablet punch residue |
| 02/26/2008 | US7335379 Analgesic, Parkinson or Alzheimer drug in a solvent system containing a monoalkyl ether of diethylene glycol, a glycol, and a mixture of a C2 to C4 alcohol and water; inhibits crystallization and transfer to clothing, improves and modulates bioavailability within skin layers; nonocclusive, semi-solid |
| 02/26/2008 | US7335378 Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers |
| 02/26/2008 | US7335377 apparatus that generates hydrophilic micro-channels, and a patch comprising the bioactive agent; for delivery of hydrophilic agents, particularly proteins such as insulin or human growth hormone |
| 02/26/2008 | US7335376 Method for photodynamic therapy and applicator for carrying out said therapy |
| 02/26/2008 | US7335371 Combinations for the treatment of inflammatory disorders |
| 02/26/2008 | US7335193 Osmotically-driven fluid dispenser |
| 02/26/2008 | CA2463001C Solution based methacholine formulations |
| 02/26/2008 | CA2430592C New pharmaceutical compositions based on anticholinergics and dopamine agonists |
| 02/26/2008 | CA2382292C Ibuprofen-containing softgels |
| 02/26/2008 | CA2333555C Controlled release preparations having multi-layer structure |
| 02/26/2008 | CA2284142C Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof |
| 02/25/2008 | CA2557241A1 Multi-functional microcapsules and method and device for manufacturing same |
| 02/21/2008 | WO2008022345A2 Compositions and methods for inhibiting cytochrome p450 |
| 02/21/2008 | WO2008022189A2 Administration of high potency platinum compound formulations by inhalation |
| 02/21/2008 | WO2008022186A2 Antimicrobial sanitizing formulations with skin protection properties |
| 02/21/2008 | WO2008022128A2 Transdermal delivery of meptazinol |
| 02/21/2008 | WO2008022043A2 Intraoperative imaging of renal cortical tumors and cysts |
| 02/21/2008 | WO2008022032A2 Topical pharmaceutical compositions comprising calcium-channel blocker and method of using same |
| 02/21/2008 | WO2008021873A2 Stabilized liquid preservative compositions |
| 02/21/2008 | WO2008021858A2 Process for manufacturing lactose |
| 02/21/2008 | WO2008021847A2 Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent |
| 02/21/2008 | WO2008021666A2 Stable liquid levetiracetam compositions and methods |
| 02/21/2008 | WO2008021548A2 Epoxy-containing poly(ester amides) and methods of use |
| 02/21/2008 | WO2008021486A1 Use of adsborbent carbon microspheres (ast-120) to treat gastroesophogeal reflux disease or symptoms thereof |
| 02/21/2008 | WO2008021347A2 Method for making solid dispersions of highly crystalline therapeutic compounds |
| 02/21/2008 | WO2008021234A2 Methods and compositions for needleless delivery of particles |
| 02/21/2008 | WO2008021149A2 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 02/21/2008 | WO2008021133A2 Osmotic delivery systems and piston assemblies |
| 02/21/2008 | WO2008021124A2 Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |
| 02/21/2008 | WO2008021113A2 Transdermal methods and systems for treating alzheimer's disease |
| 02/21/2008 | WO2008021089A2 Once-a-day (rna-polymerase inhibiting or phenazine)-dihydropteroate synthase inhibiting-dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus |
| 02/21/2008 | WO2008021057A1 Organic nanoparticles and method of preparation thereof |
| 02/21/2008 | WO2008020990A1 New direct compressible excipient blend |
| 02/21/2008 | WO2008020820A2 Pharmaceutical compositions comprising aripiprazole |
| 02/21/2008 | WO2008020748A1 Analgesic aromatic product |